Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.

Share this

The event promises to welcome first disclosures of exciting data with important learnings being communicated so the field can advance towards the first approval.

Covering the very latest from PROTACs and molecular glues in the clinic, to unveiling next generation strategies including AbTACs, DUBTACs, bioPROTACs, ATACs, RESTORACs and more, this conference is an opportunity to troubleshoot challenging problems and inspire new ideas.

We will bring our own experience of successfully employing screening strategies and methodologies for accurately measuring protein degradation.

You can find out more about our PROTAC work, along with some useful resources, here.